Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study
Primary Purpose
Oral SubMucous Fibrosis
Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
aloevera juice
Hydrocortisone
Hyaluronic Acid
antioxidant
aloevera gel
Sponsored by

About this trial
This is an interventional treatment trial for Oral SubMucous Fibrosis focused on measuring OSMF, Aloevera, Hydrocortisone, Hyaluronidase
Eligibility Criteria
Inclusion Criteria:
- Clinically diagnosed stage 2 OSMF patients.
- Patients who were ready to quit the habit and accept regular follow up protocol.
Exclusion Criteria:
- Patients with stage 1 & 3 OSMF.
- Patients with history of hypersensitivity to aloevera.
- Pregnant women & lactating mothers.
- Patients who had undergone any other treatment for OSMF.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
aloevera group
steroid group
Arm Description
aloevera juice twice daily for 3 months. aloevera gel one scoop to be applied 3-4 times daily for 3 months
intralesional injection of hydrocortisone 100mg and injection hyaluronic acid 1500IU once a week for 6 weeks with Capsules SM Fibro once daily for 3 months.
Outcomes
Primary Outcome Measures
burning sensation
Visual analogue scale
mouth opening
interincisal mouth opening was measured using a metal scale and divider from the mesioincisal angle of upper central incisor to the mesioincisal angle of lower central incisor and recorded in millimeters
cheek flexibility
Two points were marked, one on each side of the face at 1/3rd the distance from angle of the mouth on a line joining the tragus of the ear and the angle of the mouth. The distance measured between these two points was V2. The subject was asked to blow his cheek fully and the distance measured between the same two points was V1. CF=V2-V1. measured in milimeters
tongue protrusion
from mesioincisal angle of upper central incisor to the tip of the tongue when maximally extended with mouth wide open. measured in milimeters
Secondary Outcome Measures
Full Information
NCT ID
NCT02714543
First Posted
February 19, 2016
Last Updated
March 15, 2016
Sponsor
The Oxford Dental College, Hospital and Research Center, Bangalore, India
1. Study Identification
Unique Protocol Identification Number
NCT02714543
Brief Title
Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Completed
Study Start Date
November 2013 (undefined)
Primary Completion Date
August 2015 (Actual)
Study Completion Date
November 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Oxford Dental College, Hospital and Research Center, Bangalore, India
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Oral submucous fibrosis is a chronic, insidious disease caused by arecanut use and is associated with both significant morbidity (including burning sensation and reduced oral opening) and an increased risk of malignancy. Treatment of Oral SubMucous Fibrosis has largely been symptomatic and is associated with high recurrence rate. Aloevera has immunomodulatory, anti-inflammatory, wound healing, antioxidant and antineoplastic activities. All such properties of Aloevera suggest the possibility of its use in the management of oral submucous fibrosis.
In the present study, 74 patients of Oral SubMucous Fibrosis were randomly divided into 2 groups (Group A & B). Group A patients were instructed to drink 30ml of aloe vera juice twice daily before food and to apply 5mg (approx 1 scoop) of aloe vera gel over the lesion 3-4 times daily for 3 months. Group B patients were given intralesional injections of 1.5ml Hydrocortisone acetate 25mg/ml and hyaluronidase (1500 IU) weekly for 6 weeks. They were also prescribed SM Fibro (Alpha lipoic acid 50mg, Beta-carotene 10mg, Elemental copper 1mg, Elemental selenium 75mcg, Lycopene 5mg, Vitamin E 10 IU, Zinc sulphate 27.45mg in form of the capsule) for 3 months. Patients were assessed for burning sensation, interincisal mouthopening, cheek flexibility and tongue protrusion at an interval of 1, 2 and 3 months.
Detailed Description
Material and Methods The present study was conducted in the Department of Oral Medicine and Radiology at The Oxford Dental College and Hospital, Bangalore, India between November 2013 to August 2015. Approval from the institutional ethical committee was obtained for the study. Patients with Oral SubMucous Fibrosis (Stage 2 according to Pindborg) were enrolled in the study. Pregnant women, lactating mothers, patients with known history of hypersensitivity to aloevera and those who had received prior treatment for OSMF were excluded. 74 patients who were ready to quit the habit and accept regular follow up treatment protocol were included in the study. An informed consent was obtained from all the patients after the nature of the study and its procedures were explained. A thorough clinical examination was done and the following parameters were measured and recorded by an independent examiner.
The intensity of burning sensation was recorded using a Numerical Rating Visual Analogue Scale.
The interincisal mouth opening was measured using a metal scale and divider from the mesioincisal angle of upper central incisor to the mesioincisal angle of lower central incisor and recorded in millimeters.
Cheek flexibility (CF) was measured according to the method described by Bailoor and Nagesh. Two points were marked, one on each side of the face at 1/3rd the distance from angle of the mouth on a line joining the tragus of the ear and the angle of the mouth. The distance measured between these two points was V2. The subject was asked to blow his cheek fully and the distance measured between the same two points was V1. CF=V2-V1.
Tongue protrusion was assessed from normal mesioincisal angle of upper central incisor to the tip of the tongue when maximally extended with mouth wide open.
The patients were randomly divided into 2 groups (Group A & B). Group A patients were given pure aloevera gel and pure aloevera juice (Processed and manufactured by Hemant Sai, Sun Vision Company, Neel RLI Pvt Ltd). They were instructed to drink 30ml of aloevera juice twice daily before food and to apply 5mg (approx 1 scoop) of aloevera gel over the lesion 3 times per day for 3 months. Group B patients were given intralesional injections of Hydrocortisone acetate 25mg/ml and hyaluronidase (1500 IU) weekly for 6 weeks. They were also prescribed Cap SM Fibro twice daily for 3 months. Same baseline parameters were measured and recorded at an interval of 1, 2 & 3 months by the same examiner who measured the baseline values and was unaware of the treatment received by the study subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oral SubMucous Fibrosis
Keywords
OSMF, Aloevera, Hydrocortisone, Hyaluronidase
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
74 (Actual)
8. Arms, Groups, and Interventions
Arm Title
aloevera group
Arm Type
Experimental
Arm Description
aloevera juice twice daily for 3 months. aloevera gel one scoop to be applied 3-4 times daily for 3 months
Arm Title
steroid group
Arm Type
Active Comparator
Arm Description
intralesional injection of hydrocortisone 100mg and injection hyaluronic acid 1500IU once a week for 6 weeks with Capsules SM Fibro once daily for 3 months.
Intervention Type
Drug
Intervention Name(s)
aloevera juice
Intervention Description
aloevera juice to drink twice daily for 3 months.
Intervention Type
Drug
Intervention Name(s)
Hydrocortisone
Intervention Description
intralesional injection of hydrocortisone 100mg once a week for 6 weeks
Intervention Type
Drug
Intervention Name(s)
Hyaluronic Acid
Intervention Description
injection hyaluronic acid 1500IU once a week for 6 weeks
Intervention Type
Drug
Intervention Name(s)
antioxidant
Other Intervention Name(s)
Capsule SM Fibro
Intervention Description
Capsules SM Fibro (antioxidants) once daily for 3 months.
Intervention Type
Drug
Intervention Name(s)
aloevera gel
Intervention Description
aloevera gel one scoop to be applied 3-4 times daily for 3 months
Primary Outcome Measure Information:
Title
burning sensation
Description
Visual analogue scale
Time Frame
3 months
Title
mouth opening
Description
interincisal mouth opening was measured using a metal scale and divider from the mesioincisal angle of upper central incisor to the mesioincisal angle of lower central incisor and recorded in millimeters
Time Frame
3 months
Title
cheek flexibility
Description
Two points were marked, one on each side of the face at 1/3rd the distance from angle of the mouth on a line joining the tragus of the ear and the angle of the mouth. The distance measured between these two points was V2. The subject was asked to blow his cheek fully and the distance measured between the same two points was V1. CF=V2-V1. measured in milimeters
Time Frame
3 months
Title
tongue protrusion
Description
from mesioincisal angle of upper central incisor to the tip of the tongue when maximally extended with mouth wide open. measured in milimeters
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
17 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinically diagnosed stage 2 OSMF patients.
Patients who were ready to quit the habit and accept regular follow up protocol.
Exclusion Criteria:
Patients with stage 1 & 3 OSMF.
Patients with history of hypersensitivity to aloevera.
Pregnant women & lactating mothers.
Patients who had undergone any other treatment for OSMF.
12. IPD Sharing Statement
Learn more about this trial
Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study
We'll reach out to this number within 24 hrs